Here’s a shocking truth: growing older might actually be your secret weapon against cancer. Yes, you read that right—after 85, your risk of cancer could start to drop. A groundbreaking study from Stanford University (https://news.stanford.edu/stories/2025/11/extreme-advanced-age-cancer-risk-older-people-research-study) has flipped the script on what we thought we knew about aging and cancer. Using genetically engineered mice, researchers discovered that very old mice developed fewer and smaller tumors compared to their younger counterparts. But here’s where it gets controversial: could aging itself be triggering biological mechanisms that fight cancer? And this is the part most people miss—this phenomenon isn’t just in mice; it’s been observed in humans too, where cancer rates plateau or even decline after age 85. This raises a bold question: Are we overlooking the protective power of aging in cancer research?
In the study, young mice (4-6 months old) developed multiple large lung tumors, while older mice (20-21 months old) showed significantly fewer and smaller tumors. Monte Winslow, PhD, a Stanford genetics expert, admitted, ‘We expected older animals to have more severe cancers, but the opposite was true.’ The next big challenge? Unraveling how aging’s molecular changes suppress tumor growth.
But studying this relationship isn’t easy. Most cancer research relies on young animals, leaving a massive gap in our understanding of how age influences cancer. Emily Shuldiner, PhD, the study’s lead author, pointed out that older mice not only developed fewer tumors but also showed slower growth rates. Published in Nature Aging, this research underscores why age must be a key factor in cancer studies. Without it, we might be missing critical insights into how treatments work for older patients.
Now, let’s address the elephant in the room: Why does cancer risk plateau after 85? Some argue it’s due to reduced screening or survivor bias, but the Stanford study hints at something deeper—intrinsic biological mechanisms in advanced age might actively suppress tumors. Dmitri Petrov, PhD, summed it up: ‘At a certain point, aging seems to act as a natural cancer suppressor.’
Ageing isn’t just about wrinkles and gray hair; it changes cells in profound ways. DNA methylation, genome stability, and chromosomal structures all shift with age, and some of these changes may actually inhibit cancer. Shuldiner’s team found that even rapidly dividing cancer cells in older mice retained aging signatures. When they inactivated 25 tumor suppressor genes, both young and old mice saw increased tumor formation, but the effect was far more dramatic in younger mice. One gene, PTEN, showed particularly strong age-dependent effects, suggesting therapies might need to be tailored differently for older patients.
This has massive implications for cancer research. If we only study young animals, we risk missing aging-related mechanisms that could be crucial for treatment. Winslow warned, ‘Animal models must include aging to accurately guide patient therapies.’ Petrov added, ‘Aging might hold untapped potential for better cancer treatments in older adults.’
Globally, 30-50% of cancers are preventable, thanks to lifestyle changes like quitting smoking or improving diet. But what if we could also harness aging’s natural defenses? The Stanford study opens the door to new prevention and treatment strategies for the elderly.
Here’s the thought-provoking question for you: Could aging, often seen as a vulnerability, actually be a hidden strength in the fight against cancer? Share your thoughts in the comments—let’s spark a conversation that challenges conventional wisdom.
